CW Pharmacy I DST
sponsored by Inland Private Capital
CW Pharmacy I DST, sponsored by Inland Private Capital, filed its first Form D with the SEC on May 25, 2012 for a $17.9 million offering. Its last Form D, filed Oct 30, 2012, reports the offering fully sold.
How it ended
The last Form D, filed Oct 30, 2012, reports the offering fully sold.
Key facts
- Minimum investment
- $25,000From the Form D
- Offering size
- $17,977,380Equity offered, per the Form D
- Sold
- 100%Form D, Oct 30, 2012; the % is our arithmetic
- Investors reported
- Form D, Oct 30, 201271
- Selling commissions
- Form D Item 15; the % is our arithmetic$1,258,417 · 7.0% of offering
- Financing
- Leveraged. This offering reports mortgage debt on the property.How it is financed ↓
- Offered under
- Rule 506(b)General advertising and solicitation are not permitted under this exemption.
Figures come from SEC Form D filings unless a source is cited. Sponsor-stated figures are as reported by the sponsor; Top1031 does not independently audit them. On a 45-day clock? Find day 45 and day 180 →
Using this record to judge the sponsor? A licensed 1031 specialist from our affiliated partner can talk it through with you.
Ask a 1031 specialist about this recordFree. About: CW Pharmacy I DST. Top1031 is not a broker-dealer.What did CW Pharmacy I DST own?
The public record doesn't say what the building is. A Form D captures an offering's terms, not its real estate, and this Trust's filings carry no address, no square footage, and no property name. The final amendment classifies the securities only as beneficial interests in a Delaware statutory trust reflecting beneficial interests in real estate. 1 Top1031 has not matched the Trust to a specific asset.
How was it financed, and what did it cost to sell?
The filings don't disclose whether the Trust acquired its property all-cash or with mortgage debt, and no lender is named. Form D doesn't ask; a DST's loan terms live in the offering documents and the trust agreement rather than in the SEC record.
Debt
- Financing
- Leveraged. This offering reports mortgage debt on the property.
Costs and terms from the Form D
- Selling commissions
- $1,258,417 · 7.0% of offering
- Finders’ fees
- $0
- Paid to officers, directors and promoters
- $1,858,042 · 10.3% of offeringForm D Item 16
- Broker-dealers named in the Form D
- 26 named in the Form D
Show the firms
- 1st Global Capital Corp. · CRD 30349
- Cambridge Investment Research, Inc. · CRD 39543
- Centaurus Financial, Inc. · CRD 30833
- Cetera Advisors LLC · CRD 10299
- Cetera Wealth Services, LLC · CRD 13572
- Concorde Investment Services, LLC · CRD 151604
- Concourse Financial Group Securities, Inc. · CRD 15708
- G.F. Investment Services, LLC · CRD 132939
- Hagen Securities, Inc. · CRD 27353
- Independent Financial Group, LLC · CRD 7717
- Inland Securities Corporation · CRD 15807
- Investacorp, Inc. · CRD 7684
- Investment Planners, Inc. · CRD 18557
- Investors Capital Corp. · CRD 30613
- LPL Financial LLC · CRD 6413
- Money Concepts Capital Corp · CRD 12963
- NPB Financial Group, LLC · CRD 137743
- Newport Coast Securities, Inc. · CRD 16944
- Osaic FA, Inc. · CRD 3978
- Sandlapper Securities, LLC · CRD 137906
- Securities Service Network, Inc. · CRD 13318
- Sigma Financial Corporation · CRD 14303
- Summit Brokerage Services, Inc · CRD 34643
- Triad Advisors LLC · CRD 25803
- Vanderbilt Securities, LLC · CRD 5953
- XML Securities · CRD 145589
Individual representatives named in Item 12 are not listed.
- Date of first sale
- May 14, 2012
- Minimum investment
- $25,000
Form D Item 15 and Item 16 amounts may be the issuer’s estimates; each percentage is Top1031’s arithmetic on two Form D figures. Item 16 can overlap Item 15, so Top1031 does not add them together. The issuer marked these amounts as an estimate.
Who's behind CW Pharmacy I DST?
Inland Private Capital is the sponsor behind this Trust, and its filing history on EDGAR runs from this 2012 offering through programs still raising today. The Trust's Form D lists Inland Private Capital Corporation as a related person and promoter of the offering. 1 Keith Lampi signed as signatory trustee of the Trust, identified there as Senior Vice President of Inland Private Capital Corporation and a member of CW Pharmacy I Exchange, L.L.C. 1
- Sponsor
- Offerings on record
What does the SEC record show?
The initial Form D reported a date of first sale of May 14, 2012. 2 A run of amendments followed through that summer and autumn, each restating how much of the offering had been placed, and the filing record has been quiet since.
- Legal Trust name
- CW Pharmacy I DST
- SEC CIK
- 1550184
- First Form D
- May 25, 2012
- Latest Form D
- Oct 30, 2012
- Filings on record
- 8
- Offered under
- Rule 506(b)General advertising and solicitation are not permitted under this exemption.
- Source filing
SEC Form D filings, newest first
| Filed | Form | Offering amount | Amount sold | Investors | Filing on SEC EDGAR |
|---|---|---|---|---|---|
| Form D/A | $17,977,380 | $17,977,380+$883,447 | 71+5 | EDGAR | |
| Form D/A | $17,977,380 | $17,093,933+$1,464,164 | 66+8 | EDGAR | |
| Form D/A | $17,977,380 | $15,629,769+$4,238,692 | 58+13 | EDGAR | |
| Form D/A | $17,977,380 | $11,391,077+$2,668,785 | 45+9 | EDGAR | |
| Form D/A | $17,977,380 | $8,722,292+$4,870,415 | 36+19 | EDGAR | |
| Form D/A | $17,977,380 | $3,851,877+$2,053,781 | 17+8 | EDGAR | |
| Form D/A | $17,977,380 | $1,798,096+$832,424 | 9+5 | EDGAR | |
| Form D | $17,977,380 | $965,672 | 4 | EDGAR |
Amounts, investor counts and minimums are as filed with the SEC on Form D. The change lines are Top1031’s arithmetic between consecutive filings; a new Form D notice starts a new count.
A Form D is the notice a sponsor files when it starts raising money. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.
Common questions
- What happened to CW Pharmacy I DST?
- CW Pharmacy I DST is a Historical offering. The last Form D, filed Oct 30, 2012, reports the offering fully sold.
- What property did this Trust own?
- The public record doesn't say. None of the SEC filings for CW Pharmacy I DST name a property, address, tenant, or square footage, and no primary source reviewed identifies the asset. The trust name suggests a pharmacy-related retail property, but Top1031 has not confirmed that against a primary record. Similarly named Inland trusts, including CW Pharmacy II DST, are separate offerings.
- Did the Trust go full cycle, and what was the outcome?
- Baker 1031's Inland sponsor profile lists CW Pharmacy I DST as a completed full-cycle retail program and reports sponsor-stated results of a 6.92-year hold, a 1.60x equity multiple, and a 6.21% average annualized return. Those figures are sponsor-reported and secondary; no primary disposition record naming this Trust was located to corroborate them.
- Why is there so little public information on this Trust?
- A Form D is a short notice filing. It reports the issuer, the exemption claimed, the offering size, the minimum investment, and how much has been sold — not the property, the tenant, the lease, or the loan. Everything descriptive lived in the offering documents, which were delivered privately to prospective investors and never filed with the SEC.
- Who is Inland Private Capital?
- Inland Private Capital is the sponsor of record for this Trust and is named in its Form D as a related person and promoter of the offering. It has been filing 1031 exchange programs with the SEC since at least 2012 and continues to sponsor offerings today. Keith Lampi, then a Senior Vice President of the firm, signed this Trust's Form D as signatory trustee.
Sources
Show sources (3)Hide sources (3)
These links support the record as a whole; individual details may come from different sources.
DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current offering documents before investing.